Purchase high throughput microelectrode assay system plus 4 year of preventive maintenance
Ended Purchase Order Awarded Last action
- Contract number
- HHSF223201510126A
- Awardee
-
Axion Biosystems, Inc. UEI XCMKL76UJL15
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $183,328
Award facts
- Contract value 83% obligated
-
- $183,328.00 Current, with exercised options
- $219,708.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30309, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $16,901 | |
| Exercise an Option | $16,097 | |
| Exercise an Option | $15,330 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $135,000 |
About this award
This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation.
Axion Biosystems is a provider of live cell analysis technologies, including its proprietary Maestro multi-electrode array (MEA) systems and related accessories, which enable real-time monitoring of neural and cardiac activity for applications in biomedical research and drug development. The company has been awarded numerous prime federal contracts, primarily by agencies such as the National Institutes of Health (NIH), Environmental Protection Agency (EPA), and Department of Veterans Affairs (VA), to supply its specialized cell analysis platforms and related services.
Quick answers
Who was awarded contract HHSF223201510126A?
HHSF223201510126A was awarded to Axion Biosystems, Inc. by Food and Drug Administration (Department of Health and Human Services) on April 30, 2015.
How much is contract HHSF223201510126A worth?
The government has obligated $183,328 on HHSF223201510126A. Its potential value, with all options, is $219,708.
Was contract HHSF223201510126A competed?
The extent of competition for HHSF223201510126A was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award